Article · 2017
Editorial Board Member
Nan-Shan Chang
Professor, National Cheng Kung University Medical College, Taiwan
About
As published by the journal they serve.
Dr. Nan-Shan Chang is currently the Distinguished Professor of the Molecular Medicine Institute, National Cheng Kung University (NCKU) in Taiwan. He directed the Institute from 2010 to 2016. Also, he is the Adjunct Professor with the SUNY Upstate Medical University and the NYS Institute for Basic Research in Developmental Disabilities, New York. Dr. Chang is most noted for his discovery of tumor suppressor WWOX in 2000. Dr. Chang's research has focused on the role of WWOX in cancer and neural diseases. His research in NCKU has been funded by the Ministry of Science and Technology (MOST), National Health Research Institute (NHRI) and Department of Health in Taiwan, and the Department of Defense, USA.
Research interests
Journals they serve
The seats these journals name them in.
- Journal of Tumor ResearchEditorial Board Member
Articles we hold
Articles in the journals they serve whose byline carries this name.
Article
Tumor suppressor WWOX limits neurodegeneration and Zfra mitigates the symptoms of Alzheimer’s disease
Article · 2016
Role of WW domain-containing oxidoreductase WWOX in driving T-cell acute lymphoblastic leukemia maturation
Article · 2016
Role of WW domain-containing oxidoreductase WWOX in driving T-cell acute lymphoblastic leukemia maturationRole of WW domain-containing oxidoreductase WWOX in driving T-cell acute lymphoblastic leukemia maturation
Article · 2016
Role of WW domain-containing oxidoreductase WWOX in driving T-cell acute lymphoblastic leukemia maturation
Article · 2015
Tumor suppressor WWOX limits neurodegeneration and Zfra mitigates the symptoms of Alzheimer’s disease
Article · 2015
Tumor suppressor WWOX limits neurodegeneration and Zfra mitigates the symptoms of Alzheimer′s disease
This page holds what the journals publish about this profile: no contact details, and nothing gathered from anywhere else. Ask us to correct or remove this profile.